Aurora Cannabis Inc
TSX:ACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aurora Cannabis Inc
Cash Equivalents
Aurora Cannabis Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Cash Equivalents
CA$56.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
60%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash Equivalents
$1.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash Equivalents
CA$169m
|
CAGR 3-Years
32%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
24%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash Equivalents
$791.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
99%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash Equivalents
CA$5.4m
|
CAGR 3-Years
161%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-32%
|
|
Aurora Cannabis Inc
Glance View
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.
See Also
What is Aurora Cannabis Inc's Cash Equivalents?
Cash Equivalents
56.4m
CAD
Based on the financial report for Dec 31, 2025, Aurora Cannabis Inc's Cash Equivalents amounts to 56.4m CAD.
What is Aurora Cannabis Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
60%
Over the last year, the Cash Equivalents growth was -48%. The average annual Cash Equivalents growth rates for Aurora Cannabis Inc have been -40% over the past three years , -32% over the past five years , and 60% over the past ten years .
